| 摘要 |
The present invention is based, at least in part, upon discovery of a process for identifying phase changing peptides. Such phase changing peptides are capable of enhancing in vitro and in vivo delivery of oligonucleotides (e.g., dsRNAs) in lipidic, vesicular, micellar and/or naked oligonucleotide formulations. |
| 申请人 |
DICERNA PHARMACEUTICALS, INC.;BASU, SUJIT, KUMAR;BROWN, BOB, D. |
发明人 |
BASU, SUJIT, KUMAR;BROWN, BOB, D. |
